A phase II study of cisplatin(C), irinotecan (I) and bevacizumab (B) for untreated extensive stage small cell lung cancer (ES-SCLC)
- Citation:
- J Clin Oncol vol 25 (18s) abstr 7563
- Year:
- 2007
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- Yes
- Parents:
- None
- Children:
- 174
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- N. E. Ready A. Z. Dudek X Wang S. L. Graziano M. R. Green E. E. Vokes
- Networks:
- Study
- CALGB-30306
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: